For the latest in reexamination and post-grant news, and all issues of KeepIngTabs, click HERE.
In April, Bill Boshnick of Greenblum & Bernstein, PLC in Reston, Virginia recently lectured before the Japan Patent Attorneys Association (JPAA) in Tokyo and Osaka, Japan. Bill discussed export control issues and other patent problems encountered by foreign companies having U.S. subsidiaries.
Harry Gwinnell and Michael Fink presented at the Best Practices in Intellectual Property Conference on March 27-28, 2017 in Tel Aviv, Israel. G&B was a Gold Sponsor of the event. Harry was on the featured panel “THE BIG DEBATE: Patent or WHAT ELSE?” and led a Master’s Class on the Strategic Operation of a Corporate IP Department. Michael was on a panel discussing “Methods of Attacking Patents at the Patent Offices: Comparing Procedures in Europe, US and China” and also facilitated a luncheon discussion on the value of patents in the absence of infringement.
On March 1, 2017, Paul Braier spoke at the 6th Annual Pharma IPR 2017 conference in Mumbai, a leading forum for IP professionals from leading Indian and global pharma companies and law firms. Paul spoke about FDA’s new rules and guidances, and how they affect generic drug companies. For the third year running, G&B is a Silver Sponsor for this premier event. More information on the conference can be found here (http://www.pharmaipr-india.com/). Click here for a copy of the presentation.
Branko Pejic was on the organizing committee for the FICPI ABC meeting held in Miami, March 12-15, and Mr. Pejic also spoke on an international panel discussing recent intellectual property trends and developments in the Biologics and Pharmaceutical Industries. Click the following link for additional information on the FICPI ABC Conference as well as Mr. Pejic’s panel http://www.ficpi.us/
The 2016 Supplement to Post-Grant Patent Practice, Second Edition, authored by Bruce Stoner and several other former administrative patent judges, was on display at the AIPLA 2016 Annual Meeting and is now publicly available. Co-published by Bloomberg BNA and AIPLA, the treatise provides a reference guide to post-issuance procedures. The treatise can be purchased here.
G&B is proud to announce that our co-managing partner, Bruce Bernstein, has been honored as one of the world’s leading patent lawyers by Who’s Who Legal: Patents 2016, joining only four other attorneys in Virginia to receive that honor.
G&B will host JIPA’s 2016 Annual F8 Course from October 16-22, 2016. This advanced course will cover Corporate IP Management, IP Due Diligence, and Patent Monetization and Defense.
Branko Pejic spoke at the FICPI ABC meeting in Wales on June 23 on “Recent Developments in Intellectual Property Litigations and IPR/PGRs Before the USPTO
Click here for the FICPI ABC 2016 Presentation
Michael Fink was the moderator of the panel on “The HOW TO's of Using IP to Advance Business Objectives” at the Best Practices in Intellectual Property Conference on May 30, 2016. G&B was Gold Sponsor of the conference, which was held at the Sheraton in Tel Aviv, Israel.
In April, William Boshnick lectured before the Japan Patent Attorneys Association (JPAA) in Tokyo and Osaka, Japan. Boshnick discussed ways to more effectively communicate with U.S. patent counsel.
G&B is proud to announce that five of our professionals were honored as the area’s top lawyers in 2015 by Legal Leaders. Our honorees are Neil Greenblum and Michael Fink (for litigation); and Bruce Bernstein, Steve Roylance, and Barry Hollander (for Technology). A complete list of the honorees can be found here.
Bruce Bernstein, Branko Pejic and Michael Fink provided the U.S. licensing chapter in the recently published 2016 edition of Getting the Deal Through: Licensing. Click here to read the chapter.
Jill Browning and Branko Pejic presented a webcast on March 31, 2016 entitled “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries”.
Neil Greenblum and Jeff Handelsman lectured on U.S. IP law and practice to a class of approximately 100 students at the Centre for International Intellectual Property Studies, or Centre d'Etudes Internationales de la Propriété Intellectuelle (CEIPI) in Strasbourg, France from March 14-16.
Paul Braier lectured on controlling and managing litigation costs on March 9, 2016, at the 5th Annual Pharma IPR Conference in Mumbai, India. The conference hosted IPR (Intellectual Property Rights) and legal heads from India's leading pharma and biopharma companies, and patent attorneys from 15+ regions across the globe to discuss recent case studies, patent laws and litigation strategies related to Pharma IPR. A copy of Paul’s presentation will be available here shortly.
Jill M. Browning co-presented an all-day workshop on January 29, 2016 in Switzerland for Forum Institute regarding the Application and Maintenance of Market Authorization in the U.S. including GDUFA Requirements.
At the Association of Corporate Patent Counsel semi-annual meeting in Miami, Florida, Harry moderated a panel discussion with Russ Slifer, Deputy Under Secretary of Commerce for IP and Deputy Director of the USPTO. The audience-interactive discussion focused on various initiatives currently being undertaken at the US Patent and Trademark Office, and future plans. The meeting was attended by Chief IP Counsel from major U.S. corporations.
Harry Gwinnell was re-elected to serve a two year term on the IPO Education Foundation Board of Directors. The Intellectual Property Owners Education Foundation is a non-profit organization devoted to educational and charitable activities designed to improve intellectual property rights. The IPO Education Foundation conducts programs to broaden public understanding of systems for protecting intellectual property; sponsor awards for the purpose of recognizing outstanding achievement in the fields of invention, creativity, and IP rights; and publish reports dealing with legal, economic, and other aspects of intellectual property.
G&B represented Accord Healthcare in a patent infringement lawsuit brought by Millennium Pharmaceuticals over Accord Healthcare’s ANDA for bortezomib (generic for Velcade®). A 4-day bench trial was held in November 2014. On August 20, 2015, Judge Sleet (District of Delaware) rendered an opinion invalidating as obvious all asserted claims of the patent at issue. A copy of the opinion can be downloaded here.
On July 10th, Jon Miller was on the NAMM Intellectual Property Forum to share reports regarding his participation in April’s NAMM IP Academy at the USPTO, and to discuss protecting and managing intellectual property (IP).
On June 24th in Lake Tahoe, California, Harry led a panel of current and former Chief IP Counsel presenting on the corporate IP budget process, and insights on controlling costs. Panelists included Jon Wood, Chief IP Counsel of Bridgestone Americas; Cheryl Tubach, Chief IP Counsel of J.M. Huber; Roger Grobrogge, former Chief IP Counsel at Rolls Royce Americas and Dow Corning (now with ITIP ProFiciency); and Tom Quinn, former Chief IP Counsel of Schefenacker International (also now with ITIP ProFiciency).
Harry Gwinnell listed in IAM Strategy 300 – The World’s Leading IP Strategists 2015. The publication “identifies the individuals leading the way in the development and implementation of strategies that maximize the value of IP portfolios.” To be considered for listing, individuals must be nominated by at least three people from outside their organization. This is the fourth time that Harry has been selected.
Harry Gwinnell gave four IP presentations the first week of June. On Monday he presented on Patent Drafting at Rutgers University; on Wednesday on Intellectual Asset Management at Rutgers University; on Friday on Careers in Intellectual Property at George Washington University, and on Friday a SKYPE presentation on Patents as Business Tools to students at the University of New Hampshire Franklin Pierce Law Center.